Medios

Specialty Pharmaceuticalsmedios.group

Medios AG is a publicly registered German specialty pharmaceutical company that supplies specialty drugs, compounds patient-specific GMP-compliant therapies, and provides patient-specific blister packaging to pharmacies, medical specialists, and pharmaceutical companies across Germany.

Company typePublic
Founded2015
HeadquartersBerlin, Berlin, Germany
Headcount101–250
GTM typeB2B
OfferingServices

What Medios does

Medios AG is a publicly registered German specialty pharmaceutical company (Aktiengesellschaft) headquartered in Berlin that operates as the self-described market leader in Specialty Pharma in Germany. The company supplies specialty pharmaceuticals, compounds patient-specific therapies, and provides patient-specific blister packaging to a diversified customer base spanning specialized pharmacies, medical specialists, pharmaceutical companies, clinical study administrators, and nursing care facilities. Distribution is executed through a regional network of nine locations across Germany, enabling emergency patient treatment within 60 minutes.

The company's core technology centers on GMP-compliant pharmaceutical compounding performed in certified cleanroom facilities, where sterile manufacturing of cytostatics, parenteral products, and other infusions is executed based on individual patient parameters. A dedicated digital ordering platform, mediosconnect, enables 24/7 ordering and billing for medical specialists, and a 24-hour emergency phone line is maintained for hemophilia patients. The company has extended its technology stack into Advanced Therapies, acting as a compounding and commercialization partner for cell and gene technology providers.

Medios monetizes through transaction-fee-based revenue streams: specialty pharmaceutical supply, GMP compounding services, patient-specific blistering, clinical study support, and advanced therapies support. The company is operationally organized through 13 wholly-owned subsidiaries, including Medios Pharma GmbH, Cranach Pharma GmbH, Medios Blister GmbH, Logopharma Pharmagroßhandel GmbH, Fortuna Herstellung GmbH, regional Medios Solutions entities, and Medios Digital GmbH. Pricing is not publicly disclosed and is negotiated through direct B2B sales engagements and contracts.

Medios firmographics

Firmographics

Name: Medios
Legal name: Medios AG
Website: https://medios.group
Company type: Public
Founded year: 2015
Operating status: Operating
Headcount range: 101–250 employees
Short description: Medios AG is a publicly registered German specialty pharmaceutical company that supplies specialty drugs, compounds patient-specific GMP-compliant therapies, and provides patient-specific blister packaging to pharmacies, medical specialists, and pharmaceutical companies across Germany.
Ownership category
akta.pro rank

Medios industry classification

Industry

Product category: Specialty Pharmaceuticals
NAICS: Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412)
SIC: Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro primary industry: Specialty Care Pharmaceuticals (HLAIAAAB)
akta.pro secondary industries: Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

Specialty pharmaceuticals
GMP pharmaceutical compounding
Patient-specific therapies
Patient-specific blistering
Advanced therapy medicinal products

Where Medios is headquartered

Location

Headquarters

HQ city: Berlin, Berlin
HQ country: Germany
HQ region: Europe

Offices1 record

Markets served

Medios business model

Business model

GTM type: B2B
Offering type: Services
Cost components: Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

Specialty Pharmaceutical Supply: Supply of specialty pharmaceuticals to pharmacies and medical specialists. The company ensures security of supply for patients with complex diseases, providing specialty pharmaceuticals reliably and quickly across Germany through regional supply network.
GMP Compounding Services: GMP-compliant compounding of patient-specific therapies including cytostatics, parenteral products, and other infusions. These therapies are tailored to individual patient parameters such as height, weight, age, gender, tumor type, and additional diseases.
Patient-Specific Blistering: Patient-specific blister packaging service provided to pharmacies, particularly beneficial for retirement homes and nursing care services. Pharmaceuticals are packaged in easily understandable format with correct dosage for specific time periods.
Clinical Study Support: Provision of pharmaceuticals and compounding services for clinical study administrators and pharmaceutical companies conducting clinical studies.
Advanced Therapies Support: Compounding and commercialization support for advanced therapies including cell and gene technologies, serving as partner for cell and gene technology providers.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Medios product offering

Product offering

Core offering

Medios AG is the leading Specialty Pharma company in Germany, supplying specialty pharmaceuticals and compounding patient-specific therapies (cytostatics, parenteral products, other infusions) under GMP-certified cleanroom conditions. Its offering extends to patient-specific blister packaging for retirement and nursing care facilities, clinical study supply, and commercialization support for advanced therapy medicinal products (ATMPs), supported by the mediosconnect digital ordering and billing platform.

Product overview

Medios operates as a Specialty Pharma company providing a comprehensive portfolio of pharmaceutical services. The core offerings include pharmaceutical supply, GMP-compounding of patient-specific therapies (cytostatics, parenteral products, infusions), and patient-specific blistering services. The company operates an innovative digital platform called mediosconnect for order management and billing. All compounding operations are conducted in GMP-compliant cleanrooms with strict quality controls. The portfolio is complemented by a careers portal for recruitment purposes.

Differentiator

Problem solved

Functional benefit

Products and services

Pharmaceutical Supply Dependable specialty pharmaceutical supply services for pharmacies and medical specialists, ensuring security of supply and reliable delivery of specialty pharmaceuticals for patients with complex and serious diseases across Germany via a nine-location regional network.
GMP-Compounding GMP-compliant compounding of cytostatics, parenteral products and other infusions. Patient-specific therapies are tailored to individual patient parameters such as height, weight, age, gender, tumor type and additional diseases, and are produced in GMP-certified cleanrooms under strict quality controls.
Patient-Specific Blistering Patient-specific blister packaging service for modern medication management, provided to pharmacies and particularly beneficial for retirement homes and nursing care services. Pharmaceuticals are repackaged and sorted into patient-specific blister packs (tube blisters) containing the correct dosage for defined periods.
mediosconnect Browser-based order and billing platform enabling medical specialists to conveniently order patient-specific therapies and medicinal products from pharmacies around the clock (24/7). Billing is available for ophthalmology; the platform is operated by Medios Digital GmbH.
Clinical Study Support Supply of pharmaceuticals and compounding services for clinical study administrators and pharmaceutical companies conducting clinical studies.
Advanced Therapies Support Compounding and commercialization support for advanced therapies including cell and gene technologies, positioned as a partner for cell and gene technology providers and pharmaceutical companies active in advanced therapy medicinal products (ATMPs).

Quantifiable outcome

Emergency response within 60 minutes through regional supply network
+2 more outcomes

Companies that use Medios

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Medios technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Integration6 records

Feature4 records

Medios partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights6 records

Medios competitors and assessment

Company assessment

Emerging players

Aenova Group: German pharmaceutical contract developer and manufacturer (CDMO) for solid, semi-solid, sterile, and biological dosage forms. Comparable to Medios' GMP compounding capabilities, particularly in sterile manufacturing for specialty therapeutics.

Broad incumbents

Alliance Healthcare (Walgreens Boots Alliance): Global pharma wholesale and distribution arm of Walgreens Boots Alliance with strong European pharmacy supply footprint. Comparable to Medios' pharma distribution to pharmacies and medical specialists, but operating at significantly larger scale across multiple countries.
Stada Arzneimittel: German specialty and generics pharmaceutical company with broad portfolio across chronic and complex diseases. Comparable to Medios' specialty pharma positioning and German operational base, though Stada operates as a manufacturer rather than a compounder/distributor.
McKesson: Largest North American pharma distributor with growing European specialty footprint. Comparable to Medios' pharmaceutical supply and specialty pharma positioning; broad incumbent serving hospitals, pharmacies, and manufacturers.
Cardinal Health: Major US-based pharmaceutical and medical product distributor with global specialty operations. Comparable business model to Medios in pharma distribution, GMP-compliant operations, and serving specialty care providers.
AmerisourceBergen (Cencora): Global pharmaceutical distribution and specialty services company. Comparable to Medios through its specialty distribution operations serving pharmacies and clinical study operators, though at vastly larger scale.

Direct peers

PHOENIX Group: Europe's largest pharmaceutical wholesale and distribution group, headquartered in Germany. Directly comparable to Medios' specialty pharmaceutical supply and broader distribution model across pharmacy customers in Germany and Europe.
GEHE Pharma Handel: German pharmaceutical wholesaler (subsidiary of PHOENIX Group) serving pharmacies nationwide. Direct competitor to Medios' specialty pharma supply and pharmacy distribution business in Germany.
NOVENTI Health: German healthcare services and pharmacy network serving statutory health insurance billing and pharmaceutical supply. Comparable to Medios as a German-headquartered pharma services platform targeting pharmacies and medical specialists.
Celesio / McKesson Europe: European pharmaceutical distribution and pharmacy operator (Lloyds Pharmacy in UK, wholesale operations across Europe). Direct competitor to Medios in German and European pharma supply to pharmacies.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Medios compliance and trust

Trust signal

Compliance3 records

Medios financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Medios leadership team

Management profile

Number of profiles

Profiles4 records

Medios subsidiaries and ownership

Company hierarchy

Subsidiaries13 records

Medios funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Medios M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medios

What does Medios do?

Is Medios a public or private company?

Medios is a public company. It is classified as public and is currently operating.

When was Medios founded?

Medios was founded in 2015. It employs 101 to 250 people.

Where is Medios based?

Medios is headquartered in Berlin, Berlin, Germany, in the Europe region.

How does Medios make money?

Five revenue lines are on record. Specialty Pharmaceutical Supply is the primary driver. The others are GMP Compounding Services, patient-Specific Blistering, clinical Study Support and advanced Therapies Support.

Who are Medios's main competitors?

Aenova Group is listed as an emerging player. Broad incumbents are Alliance Healthcare (Walgreens Boots Alliance), Stada Arzneimittel, McKesson, Cardinal Health and AmerisourceBergen (Cencora). Direct peers are PHOENIX Group, GEHE Pharma Handel, NOVENTI Health and Celesio / McKesson Europe.

Does Medios have an API?

No public API is recorded for Medios.

What industry is Medios in?

Medios's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAB, Specialty Care Pharmaceuticals, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 424210 and its SIC code is 5122.